Whereas the wild-type NPM1 inhibits Akt phosphorylation, the AML-associated NPM1 mutants can prevent the nuclear localization of Akt and promote Akt phosphorylation [257]. The gene discussed is NPM1; the disease is acute myeloid leukemia.